Aurinia Pharmaceuticals (AUP) News Today → The Gold Grab of the Century (From Colonial Metals) (Ad) Free AUP Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAurinia Pharmaceuticals Inc.barrons.com - February 29 at 10:41 PMAurinia Pharmaceuticals Finds No Buyer After Strategic Business Review, Launches Stock Buybackmsn.com - February 15 at 7:22 PMExclusive-Kidney drug developer Aurinia fails to clinch a sale, sources saymsn.com - February 15 at 2:21 PMAurinia Pharma GAAP EPS of -$0.19 misses by $0.03, revenue of $45.1M misses by $0.06Mmsn.com - February 15 at 9:20 AMAurinia drops after Q4 miss; strategic review failsmsn.com - February 15 at 9:20 AMAurinia to stop development of immunotherapies after strategic reviewreuters.com - February 15 at 9:20 AMExclusive: Kidney drug developer Aurinia fails to clinch a sale, sources sayreuters.com - February 15 at 9:20 AMAurinia Pharma Q4 2023 Earnings Previewmsn.com - February 14 at 12:58 PMAnalysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA) and Arrowhead Pharmaceuticals (ARWR)markets.businessinsider.com - February 8 at 3:31 PMAurinia Pharmaceuticals (AUPH) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Releasemsn.com - February 8 at 3:31 PMAurinia Pharmaceuticals Announces Collaboration Partner Otsuka Filed New Drug Application (NDA) for LUPKYNIS® (Voclosporin) in Japanbenzinga.com - November 13 at 8:23 AMAurinia Says Its Partner Otsuka Filed NDA For Voclosporin In Japanmarkets.businessinsider.com - November 13 at 8:23 AMStrong 3Q Performance and Growing Lupkynis Sales Bolster Aurinia Pharmaceuticals’ Buy Rating: An In-depth Analysis by David Martin, PhDmarkets.businessinsider.com - November 6 at 9:04 AMAurinia Pharmaceuticals Inc. (AUPH) Q3 2023 Earnings Call Transcriptseekingalpha.com - November 2 at 10:38 PMAurinia Pharmaceuticals: Reassessing As It Gains Tractionmsn.com - September 27 at 2:56 PMAurinia Pharmaceuticals Inc. (AUPH) Q2 2023 Earnings Call Transcriptseekingalpha.com - August 3 at 3:15 PMAurinia Pharmaceuticals Stock Returns To A Rising Relative Strengthmsn.com - July 18 at 1:16 PMAurinia Board of Directors Announces Exploration of Strategic Alternatives to Maximize Shareholder Valuebenzinga.com - June 29 at 7:45 PMAurinia Pharmaceuticals: Still In The Game With Lupkynis Salesmsn.com - June 16 at 6:17 PMAurinia Pharmaceuticals Earnings Perspective: Return On Capital Employedmsn.com - May 18 at 3:21 PMMKT Capital Thanks Fellow Shareholders for Their Strong Support at Aurinia's 2023 Annual Meetingtechnews.tmcnet.com - May 17 at 4:02 PMNews Flash: Analysts Just Made A Sizeable Upgrade To Their Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Forecastsfinance.yahoo.com - May 9 at 8:55 AMBloom Burton Remains a Buy on Aurinia Pharmaceuticals (AUPH)markets.businessinsider.com - May 6 at 10:22 PMMKT Capital Issues Statement Regarding Aurinia's Disappointing First Quarter 2023 Financial Resultstechnews.tmcnet.com - May 5 at 11:19 AMAurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Resultsfinance.yahoo.com - May 4 at 8:45 AMAurinia Pharma gains after Q1 beat and guidance raisemsn.com - May 4 at 8:45 AMAurinia Pharmaceuticals: Q1 Earnings Insightsmsn.com - May 4 at 8:45 AMISS Recommends Aurinia Shareholders Vote Against the Company’s Named Executive Officers’ Compensationtheglobeandmail.com - May 3 at 5:44 PMToni Braxton and Aurinia Want People with Lupus Nephritis to Get Uncomfortable to Protect their Kidneysfinance.yahoo.com - April 25 at 1:02 PMMKT Capital Issues Letter to Aurinia Shareholders Announcing its Intention to Withhold Support for Three Directors at 2023 Annual Meetingmarketwatch.com - April 25 at 2:05 AMWhy Aurinia Pharmaceuticals Stock Is Glowing Green Todaymsn.com - April 11 at 3:58 PMWe Think Aurinia Pharmaceuticals (NASDAQ:AUPH) Can Easily Afford To Drive Business Growthfinance.yahoo.com - April 4 at 8:00 AMAurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2022 Earnings Call Transcriptinsidermonkey.com - March 9 at 3:11 PMAurinia Pharmaceuticals (AUPH) Expected to Beat Earnings Estimates: Should You Buy?msn.com - February 21 at 12:20 PMAurinia Announces PTAB Has Terminated Inter Partes Reviewyahoo.com - January 25 at 3:36 PMAnalysts Offer Insights on Healthcare Companies: Taro Pharmaceutical (TARO) and Aurinia Pharmaceuticals (AUPH)markets.businessinsider.com - January 25 at 10:36 AMAurinia adds 11% amid patent wins in the U.S. and EUmsn.com - January 25 at 10:36 AMInvestors ignore increasing losses at Aurinia Pharmaceuticals (NASDAQ:AUPH) as stock jumps 21% this past weeknz.finance.yahoo.com - January 16 at 9:33 AMAurinia Provides Preliminary Unaudited Fourth Quarter and Full-year 2022 Net Revenue Resultsbenzinga.com - January 6 at 8:14 AMAurinia's Patent Dispute Is Over, But Without A Buyout, There's No Upsideseekingalpha.com - January 5 at 4:10 PMAurinia Pharmaceuticals gains amid M&A speculation following patent settlementmsn.com - January 4 at 12:26 PMAurinia (AUPH) Soars 37.5%: Is Further Upside Left in the Stock?nasdaq.com - January 4 at 7:26 AMAurinia Pharma Shares Rise 37% After Patent Settlement With Sun Pharmamarketwatch.com - January 3 at 12:19 PMAurinia Announces the Great Britain Marketing Authorization of LUPKYNIS® (voclosporin) for the Treatment of Lupus Nephritisfinance.yahoo.com - November 30 at 6:28 PMAurinia Pharmaceuticals Inc. (AUPH) Q3 2022 Earnings Call Transcriptseekingalpha.com - November 3 at 1:51 PMRecap: Aurinia Pharmaceuticals Q3 Earningsmsn.com - November 3 at 8:47 AMAurinia sheds 22% as lackluster Lupkynis uptake leads to guidance cutseekingalpha.com - November 3 at 8:47 AMEarnings Preview For Aurinia Pharmaceuticalsmsn.com - November 2 at 5:45 PMAurinia Pharmaceuticals Announces Presentations at American Society of Nephrology (ASN) Kidney Week 2022benzinga.com - October 27 at 2:41 PMAUPH Aurinia Pharmaceuticals Inc.seekingalpha.com - October 21 at 10:14 PM Get Aurinia Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AUP and its competitors with MarketBeat's FREE daily newsletter. Email Address If you have $2,500 bucks… check this out (Ad)This computer whiz has been averaging 234% per year with an undefeated strategy he calls… The “Income Glitch” And he’s been making out like a bandit with a 100% success rate on over 64 trade opportunities! Click here to unlock the Income Glitch training workshop for free. AUP Media Mentions By Week AUP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AUP News Sentiment▼0.000.38▲Average Computer and Technology News Sentiment AUP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AUP Articles This Week▼00▲AUP Articles Average Week Get Aurinia Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AUP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Docebo News Enghouse Systems News Nuvei News Lightspeed Commerce News Hammond Power Solutions News TELUS International (Cda) News Converge Technology Solutions News Softchoice News Evertz Technologies News Dye & Durham News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:AUP) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurinia Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
